Search for: "KV Pharmaceutical" Results 1 - 20 of 92
Sorted by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
2 Jul 2012, 6:57 am by thehealthlawfirm
Eighth Circuit Court of Appeals ruled that investors can continue to bring claims against KV Pharmaceutical Co. [read post]
15 Dec 2011, 11:28 am by admin
KV Pharmaceutical (KV), the parent company for Ethex Corporation (Ethex), this month agreed to pay $17 million to settle claims that Ethex of violated the False Claims Act when it allegedly reported false information to the Centers for Medicare and Medicaid Services (CMS). [read post]
12 Oct 2011, 6:38 am
Louis, I have followed the trials and tribulations of local pharmaceutical company KV Pharmaceutical. [read post]
24 Oct 2012, 3:51 pm by Eric Schweibenz
  KV maintains that “[g]iven the status of Makena®’s orphan drug designation and market exclusivity, KV constitutes the entire domestic [HPC] pharmaceutical industry. [read post]
23 Dec 2008, 8:57 pm
At Same Time, KV Pharmaceutical Suspends Shipments of All ETHEX Tablet-Form Drugs For An Indefinite Period (Posted by Tom Lamb at DrugInjuryWatch.com) On December 23, 2008 KV Pharmaceutical announced another drug recall involving its subsidiary ETHEX Corporation. [read post]
17 Aug 2012, 6:41 am by Reed Allmand
Louis based KV Pharmaceutical files for Chapter 11 bankruptcy protection after dealing with manufacturing issues along with weak sales of its birth control drug Makena. [read post]
26 Feb 2010, 6:11 am
Zambri, founding partner      The AP reported that "Drugmaker KV Pharmaceutical Co. says it will shut down its Ethex generic division, plead guilty to criminal charges" that the company failed to immediately notify "regulators of safety hazards. [read post]
26 Jan 2010, 3:33 pm
On November 7, 2008 Ethex Corporation, a subsidiary of KV Pharmaceuticals, issued a nationwide recall of five of its generic drugs. [read post]
1 Mar 2012, 9:30 pm by eithurburn@getnicklaw.com
  KV Pharmaceutical company will pay $17 million for allegedly accepting Medicaid reimbursement for drugs which were deemed “less than effective” by the FDA, and thus were ineligible for reimbursement by federal healthcare programs. [read post]
17 Jun 2009, 9:58 pm
By Suresh Pillai -- Settlement Announced in Oxycontin ® Litigation KV Pharmaceutical Co. announced a settlement in its litigation with Purdue Pharma LP over the painkiller Oxycontin ® (see "Court Report," June 11, 2007). [read post]
6 Dec 2011, 8:10 pm by eithurburn@getnicklaw.com
Louis-Based KV Pharmaceutical to Pay $17 Million to Settle False Claims Allegations Received Reimbursement for Unapproved Drugs" [read post]
15 Apr 2009, 8:56 pm
By Suresh Pillai -- Resolution Announced in Johnson & Johnson Razadyne ® ER Patent Litigation Johnson & Johnson units Janssen LP, Janssen Pharmaceutica NV, and Ortho-McNeil Neurologics have stipulated to a dismissal with prejudice of all claims of patent infringement against KV Pharmaceutical Co., Barr Pharmaceuticals Inc., and Sandoz Inc. with respect to a generic version of Razadyne ® ER. [read post]
10 Mar 2011, 9:15 pm by Ben Vernia
Louis-based KV Pharmaceutical Company, pleaded guilty and was sentenced today in a case involving KV’s production and distribution of oversized morphine sulfate tablets, the Justice Department announced. [read post]
3 Apr 2011, 11:51 am by Lawrence B. Ebert
When KV announced it would charge about hundred times what patients were paying at compounding pharmacies, a firestorm of criticism ensued, and the pharmaceutical company has backpedaled on its pricing.As to --more regulated and readily available version of the shot --, the best laid plans can lead to unexpected consequences. [read post]